Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES MODEL
4.2 PESTEL ANALYSIS
5 INDUSTRY INSIGHTS: MIDDLE EAST & AFRICA NASAL SPRAY MARKET
5.1 INDUSTRY INSIGHTS
6 REGULATIONS: MIDDLE EAST & AFRICA NASAL SPRAY MARKET
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASE IN INFECTION AND ALLERGIC CASES
7.1.2 RISING PREVALENCE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND ASTHMA
7.1.3 EFFECTIVENESS OVER OTHER FORMS OF DRUG DELIVERY
7.1.4 IMPROVING PATIENT COMPLIANCE AND ACCEPTABILITY
7.2 RESTRAINTS
7.2.1 PRODUCT RECALLS
7.2.2 ADVERSE EFFECTS OF USING NASAL SPRAYS
7.3 OPPORTUNITIES
7.3.1 NEW RISING DEMAND FOR SELF-ADMINISTRATIVE DRUG DELIVERY
7.3.2 EXPANDING THERAPEUTIC APPLICATIONS FOR NASAL SPRAYS
7.3.3 STRATEGIC INITIATIVES TAKEN BY KEY MARKET PLAYERS
7.4 CHALLENGES
7.4.1 REGULATORY HURDLES
7.4.2 ADDICTION TO NASAL SPRAY
8 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 DECONGESTION NASAL SPRAY
8.3 STEROID NASAL SPRAY
8.4 SALT WATER SOLUTION/SALINE NASAL SPRAY
8.5 OTHERS
9 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY CONTAINER DESIGN
9.1 OVERVIEW
9.2 PUMP BOTTLES
9.3 PRESSURIZED CANISTERS
10 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY DOSAGE FORM
10.1 OVERVIEW
10.2 MULTI DOSE
10.3 UNIT/SINGLE DOSE
10.4 BI DOSE
11 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS
11.1 OVERVIEW
11.2 ANTIHISTAMINE
11.3 NASAL STEROIDS
11.4 MAST CELL INHIBITOR
11.5 ANTICHOLINERGIC
12 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 NASAL CONGESTION
12.3 ALLERGIC AND NON-ALLERGIC RHINITIS
12.4 CENTRAL NERVOUS SYSTEM DISORDERS
12.5 VACCINATION
12.6 OTHERS
13 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY
13.1 OVERVIEW
13.2 PRESCRIBED
13.3 OVER THE COUNTER
14 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY END USER
14.1 OVERVIEW
14.2 HOME CARE SETTINGS
14.3 HOSPITALS
14.4 CLINICS
14.5 COMMUNITY HEALTH CARE
15 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY REGION
15.1 MIDDLE EAST AND AFRICA
15.1.1 SOUTH AFRICA
15.1.2 UAE
15.1.3 SAUDI ARABIA
15.1.4 REST OF MIDDLE EAST & AFRICA
16 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 GLAXOSMITHKLINE PLC.
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 PFIZER INC.
18.2.1 COMPANY SNAPSHOT
18.2.2 REVENUE ANALYSIS
18.2.3 COMPANY SHARE ANALYSIS
18.2.4 PRODUCT PORTFOLIO
18.2.5 RECENT DEVELOPMENTS
18.3 EMERGENT
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENT
18.4 SANDOZ INTERNATIONAL GMBH (A PART OF NOVARTIS)
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 COMPANY SHARE ANALYSIS
18.4.4 PRODUCT PORTFOLIO
18.4.5 RECENT DEVELOPMENT
18.5 CATALENT, INC.
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 COMPANY SHARE ANALYSIS
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPMENTS
18.6 AYTU HEALTH (A SUBSIDIARY OF AYTU BIOPHARMA, INC.)
18.6.1 COMPANY SNAPSHOT
18.6.2 REVENUE ANALYSIS
18.6.3 PRODUCT PORTFOLIO
18.6.4 RECENT DEVELOPMENTS
18.7 AISHWARYA GROUP
18.7.1 COMPANY SNAPSHOT
18.7.2 PRODUCT PORTFOLIO
18.7.3 RECENT DEVELOPMENTS
18.8 ASSERTIO THERAPEUTICS, INC.
18.8.1 COMPANY SNAPSHOT
18.8.2 REVENUE ANALYSIS
18.8.3 PRODUCT PORTFOLIO
18.8.4 RECENT DEVELOPMENT
18.9 AURENA LABORATORIES.
18.9.1 COMPANY SNAPSHOT
18.9.2 PRODUCT PORTFOLIO
18.9.3 RECENT DEVELOPMENTS
18.1 BAYER AG
18.10.1 COMPANY SNAPSHOT
18.10.2 REVENUE ANALYSIS
18.10.3 COMPANY SHARE ANALYSIS
18.10.4 PRODUCT PORTFOLIO
18.10.5 RECENT DEVELOPMENTS
18.11 CIPLA INC.
18.11.1 COMPANY SNAPSHOT
18.11.2 REVENUE ANALYSIS
18.11.3 PRODUCT PORTFOLIO
18.11.4 RECENT DEVELOPMENT
18.12 J PHARMACEUTICALS.
18.12.1 COMPANY SNAPSHOT
18.12.2 PRODUCT PORTFOLIO
18.12.3 RECENT DEVELOPMENTS
18.13 LEEFORD HEALTHCARE LTD
18.13.1 COMPANY SNAPSHOT
18.13.2 PRODUCT PORTFOLIO
18.13.3 RECENT DEVELOPMENTS
18.14 ST. RENATUS.
18.14.1 COMPANY SNAPSHOT
18.14.2 PRODUCT PORTFOLIO
18.14.3 RECENT DEVELOPMENTS
18.15 TEVA PHARMACEUTICALS USA, INC. (A SUBSIDIARY OF TEVA PHARMACEUTICAL INDUSTRIES LTD)
18.15.1 COMPANY SNAPSHOT
18.15.2 REVENUE ANALYSIS
18.15.3 PRODUCT PORTFOLIO
18.15.4 RECENT DEVELOPMENTS
18.16 ULTRATECH INDIA LIMITED
18.16.1 COMPANY SNAPSHOT
18.16.2 PRODUCT PORTFOLIO
18.16.3 RECENT DEVELOPMENTS
18.17 VIATRIS INC.
18.17.1 COMPANY SNAPSHOT
18.17.2 REVENUE ANALYSIS
18.17.3 COMPANY SHARE ANALYSIS
18.17.4 PRODUCT PORTFOLIO
18.17.5 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
List of Table
TABLE 1 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 2 MIDDLE EAST & AFRICA DECONGESTION NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 MIDDLE EAST & AFRICA STEROID NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 4 MIDDLE EAST & AFRICA SALT WATER SOLUTION/SALINE NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA OTHERS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA PUMP BOTTLES IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA PRESSURIZED CANISTERS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA MULTI DOSE IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA UNIT/SINGLE DOSE IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA BI DOSE IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA ANTIHISTAMINE IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA NASAL STEROIDS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA MAST CELL INHIBITOR IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA ANTICHOLINERGIC IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA NASAL CONGESTION IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA ALLERGIC AND NON-ALLERGIC RHINITIS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA CENTRAL NERVOUS SYSTEM DISORDERS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA VACCINATION IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA OTHERS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA PRESCRIBED IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA OVER THE COUNTER IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA HOME CARE SETTINGS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA HOSPITALS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA CLINICS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA COMMUNITY HEALTH CARE IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 38 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION)
TABLE 39 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 40 SOUTH AFRICA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 41 SOUTH AFRICA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION)
TABLE 42 SOUTH AFRICA NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION)
TABLE 43 SOUTH AFRICA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION)
TABLE 44 SOUTH AFRICA NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 45 SOUTH AFRICA NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION)
TABLE 46 SOUTH AFRICA NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 47 UAE NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 48 UAE NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION)
TABLE 49 UAE NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION)
TABLE 50 UAE NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION)
TABLE 51 UAE NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 52 UAE NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION)
TABLE 53 UAE NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 54 SAUDI ARABIA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 55 SAUDI ARABIA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION)
TABLE 56 SAUDI ARABIA NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION)
TABLE 57 SAUDI ARABIA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION)
TABLE 58 SAUDI ARABIA NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 59 SAUDI ARABIA NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION)
TABLE 60 SAUDI ARABIA NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 61 REST OF MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
List of Figure
FIGURE 1 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: SEGMENTATION
FIGURE 11 THE INCREASE IN INFECTION AND ALLERGIC CASES IS EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA NASAL SPRAY MARKET IN THE FORECAST PERIOD
FIGURE 12 THE DECONGESTION NASAL SPRAY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA NASAL SPRAY MARKET IN 2023 AND 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST & AFRICA NASAL SPRAY MARKET
FIGURE 14 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY PRODUCT TYPE, 2022
FIGURE 15 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 16 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 17 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY CONTAINER DESIGN, 2022
FIGURE 19 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY CONTAINER DESIGN, 2023-2030 (USD MILLION)
FIGURE 20 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY CONTAINER DESIGN, CAGR (2023-2030)
FIGURE 21 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY CONTAINER DESIGN, LIFELINE CURVE
FIGURE 22 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY DOSAGE FORM, 2022
FIGURE 23 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY DOSAGE FORM, 2023-2030 (USD MILLION)
FIGURE 24 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY DOSAGE FORM, CAGR (2023-2030)
FIGURE 25 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY DOSAGE FORM, LIFELINE CURVE
FIGURE 26 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY THERAPEUTIC CLASS, 2022
FIGURE 27 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY THERAPEUTIC CLASS, 2023-2030 (USD MILLION)
FIGURE 28 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY THERAPEUTIC CLASS, CAGR (2023-2030)
FIGURE 29 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY THERAPEUTIC CLASS, LIFELINE CURVE
FIGURE 30 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY APPLICATION, 2022
FIGURE 31 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 32 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 33 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 34 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY PRESCRIPTION/AVAILABILITY, 2022
FIGURE 35 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY PRESCRIPTION/AVAILABILITY, 2023-2030 (USD MILLION)
FIGURE 36 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY PRESCRIPTION/AVAILABILITY, CAGR (2023-2030)
FIGURE 37 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY PRESCRIPTION/AVAILABILITY, LIFELINE CURVE
FIGURE 38 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY END USER, 2022
FIGURE 39 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 40 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY END USER, CAGR (2023-2030)
FIGURE 41 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY END USER, LIFELINE CURVE
FIGURE 42 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: SNAPSHOT (2022)
FIGURE 43 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: BY COUNTRY (2022)
FIGURE 44 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: BY COUNTRY (2023 & 2030)
FIGURE 45 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: BY COUNTRY (2022 & 2030)
FIGURE 46 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: PRODUCT TYPE (2023-2030)
FIGURE 47 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: COMPANY SHARE 2022 (%)
